New study finds high dose tofacitinib is safe and effective in COVID patients with pneumonitis and may prevent deterioration to respiratory failure. Open-labelled study with 116 patients, 15.5% of tofacitinib group progressed to non-invasive ventilation, compared to 29.3% in control group. Published in European Journal of Clinical Investigation.
New study finds high dose tofacitinib is safe and effective in COVID patients with pneumonitis and may prevent deterioration to respiratory failure. Open-labelled study with 116 patients, 15.5% of tofacitinib group progressed to non-invasive ventilation, compared to 29.3% in control group. Published in European Journal of Clinical Investigation.
New study finds high dose tofacitinib is safe and effective in COVID patients with pneumonitis and may prevent deterioration to respiratory failure. Open-labelled study with 116 patients, 15.5% of tofacitinib group progressed to non-invasive ventilation, compared to 29.3% in control group. Published in European Journal of Clinical Investigation.
New study finds high dose tofacitinib is safe and effective in COVID patients with pneumonitis and may prevent deterioration to respiratory failure. Open-labelled study with 116 patients, 15.5% of tofacitinib group progressed to non-invasive ventilation, compared to 29.3% in control group. Published in European Journal of Clinical Investigation.
New study finds high dose tofacitinib is safe and effective in COVID patients with pneumonitis and may prevent deterioration to respiratory failure. Open-labelled study with 116 patients, 15.5% of tofacitinib group progressed to non-invasive ventilation, compared to 29.3% in control group. Published in European Journal of Clinical Investigation.
New study finds high dose tofacitinib is safe and effective in COVID patients with pneumonitis and may prevent deterioration to respiratory failure. Open-labelled study with 116 patients, 15.5% of tofacitinib group progressed to non-invasive ventilation, compared to 29.3% in control group. Published in European Journal of Clinical Investigation.
The implementation of Artificial Intelligence (AI) in healthcare services may bring many benefits, including: All told, the use
The implementation of Artificial Intelligence (AI) in healthcare services may bring many benefits, including: All told, the use of AI in healthcare
The implementation of Artificial Intelligence (AI) in healthcare services may bring many benefits, including: All told, the use of AI in healthcare may bring significant